Zanamivir-13C,15N2 Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Zanamivir-¹³C,¹⁵N₂ is intended for use as an internal standard for the quantification of zanamivir by GC- or LC-MS. Zanamivir is a sialic acid analog that inhibits neuraminidase release of newly replicated influenza virus particles. It has been shown to selectively inhibit the growth of influenza A and B viruses in plaque reduction assays with IC₅₀ values ranging from 5 to 14 nM and to directly inhibit influenza A and B virus neuraminidases with IC₅₀ values ranging from 0.6 to 7.9 nM in vitro. Intranasal zanamivir administration at 0.4 mg/kg twice daily reduces mortality and viral titers in lung homogenates of mice infected with influenza.

Chemische Eigenschaften

White Solid

Verwenden

Influenza viral neuraminidase inhibitor; structural analog of the sialic acid. Antiviral.

Zanamivir-13C,15N2 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Zanamivir-13C,15N2 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Chemsky（shanghai）International Co.,Ltd.	021-50135380	shchemsky@sina.com	China	32321	50
Cato Research Chemicals Inc.	020-81960175	min.he@cato-chem.com	China	1955	55
Energy Chemical	021-58432009 400-005-6266	marketing1@energy-chemical.com	China	44807	58
ChemeGen 中國	18818260767	2625930290@qq.com	China	6973	58
LGC Science (Shanghai) Ltd.	17717235263	cindy.yang@lgcgroup.com	China	17730	58
guoyungurui	18162595016; 18162595016	3287908757@qq.com	China	10335	58

---

• Zanamivir-13C,15N2
• [13C,15N2]-Zanamivir
• Amitriptyline Impurity 2( Amitriptyline EP Impurity B)
• 1276528-62-1
• C1113CH20N215N2O7
• Anti-virals
• Intermediates & Fine Chemicals
• Isotope Labelled Compounds
• Pharmaceuticals